1.	Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome Phase: Phase II Type: Treatment Status: Active Age: 16 to 50 Sponsor: NCI, Other Protocol IDs: 1809.00, NCI-2010-00234, FHCRC-1809.00, 5602, NCT00119366
2.	Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia or High-Risk Myelodysplastic Syndrome Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2186.00, NCI-2010-00404, P01CA044991, FHCRC-2186.00, NCT00589316
3.	Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2238.00, NCI-2010-00128, P01CA044991, FHCRC-2238.00, IR-6844, MCLI-07-002, NCT00860171